Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study

Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study

Junjie Lu1,2 *, Xiang Chen1,2 *, Yongfa Liu,1,2 Yi Ding,1,2 Bo Li,1,2 Jin Yang,1,2 Wei Peng,3 Xiaoli Yang1,2 1Department of General Surgery (Hepatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China; 2NuclearMedicine a...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu J, Chen X, Liu Y, Ding Y, Li B, Yang J, Peng W, Yang X
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Hepatocellular carcinoma
Transarterial chemoembolization
Molecular targeted treatments
Tyrosine kinase inhibitor
Programmed death-(ligand)1 inhibitors
Retrospective cohort study
Online Access:https://www.dovepress.com/transarterial-chemoembolization-molecular-targeted-treatments-and-prog-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/transarterial-chemoembolization-molecular-targeted-treatments-and-prog-peer-reviewed-fulltext-article-JHC

Similar Items